Showing 1 - 10 of 611
suggest that misinformation and related consumer mistakes explain a sizable share of the brand premium for health products …
Persistent link: https://www.econbiz.de/10013050309
Consumers often benefit from increased competition in differentiated product settings. In this paper we consider consumer benefits from increased competition in a differentiated product setting: the spread of non-traditional retail outlets. In this paper we estimate consumer benefits from...
Persistent link: https://www.econbiz.de/10013234406
The one-shot nature of most theoretical models of strategic investment, especially those based on asymmetric information, limits our ability to test whether they can fit the data. We develop a dynamic version of the classic Milgrom and Roberts (1982) model of limit pricing, where a monopolist...
Persistent link: https://www.econbiz.de/10013050311
Online data was collected for 350,000 products from over 65 fashion retailers in the U.S. and the U.K. Many retailers …
Persistent link: https://www.econbiz.de/10013323627
Branded pharmaceutical manufacturers frequently offer "copay coupons'" that insulate consumers from cost-sharing, thereby undermining insurers' ability to influence drug utilization. We study the impact of copay coupons on branded drugs first facing generic entry between 2007 and 2010. To...
Persistent link: https://www.econbiz.de/10012981093
branded equivalent, while the retailer's margin on the national brand is an upper bound on the retailer's marginal handling … cost for both the brand and private label versions. We find that lower bounds on the 'full' markup ratio range from 3 …
Persistent link: https://www.econbiz.de/10014126776
Empirical studies suggest that entry of generic competitors results in minimal decreases or even increases in brand …-name drug prices as well as sharp declines in brand-name advertising. This paper examines circumstances under which this … empirical pattern could be observed. The analysis focuses on models where the demand for brand-name pharmaceuticals is divided …
Persistent link: https://www.econbiz.de/10013226930
Investments in brand provide one method for vendors to become known and convince potential customers that vendors will … their commitments can serve a similar function and may undermine investments in brand. This study uses a 13-month panel … whether information use undermines brand. We find that individuals who take up using price comparison sites reduce their …
Persistent link: https://www.econbiz.de/10013244355
This paper examines why physicians continue to prescribe trade- name drugs when less expensive generic substitutes are available. I utilize a data set on physicians, their patients, and the multi-source drugs prescribed to study the prescription habits of physicians in prescribing generic and...
Persistent link: https://www.econbiz.de/10013247652
We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all patent rights on branded prescription drugs are eliminated for both existing and future prescription drugs without compensation to the patent holders. The question of whether this...
Persistent link: https://www.econbiz.de/10013212342